Halbert Hargrove Global Advisors, LLC Novo Nordisk A S Transaction History
Halbert Hargrove Global Advisors, LLC
- $2.02 Billion
- Q3 2025
A detailed history of Halbert Hargrove Global Advisors, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Halbert Hargrove Global Advisors, LLC holds 549 shares of NVO stock, worth $29,036. This represents 0.0% of its overall portfolio holdings.
Number of Shares
549
Previous 549
-0.0%
Holding current value
$29,036
Previous $37,000
18.92%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding NVO
# of Institutions
1,708Shares Held
312MCall Options Held
13.7MPut Options Held
19.7M-
Jennison Associates LLC18.9MShares$999 Million0.78% of portfolio
-
Bank Of America Corp Charlotte, NC14.7MShares$779 Million0.08% of portfolio
-
Morgan Stanley New York, NY14.3MShares$756 Million0.07% of portfolio
-
Loomis Sayles & CO L P12.6MShares$665 Million1.12% of portfolio
-
Capital International Investors Los Angeles, CA11.6MShares$615 Million0.14% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $119B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...